Bioreliance Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United Kingdom
- Registered address
- Todd Campus Glasgow West of Scotland Science Park, Glasgow Lanarkshire, Scotland G20 OXA, United Kingdom (GBR)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3005343934 · DUNS 505004556
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-05-13
- VAIVaccines and Allergenic Products2025-12-05
- NAIVaccines and Allergenic Products2023-11-07
- VAIDrug Quality Assurance2021-03-17
- VAIDrug Quality Assurance2019-09-27
- VAIVaccines and Allergenic Products2019-03-15
- VAIDrug Quality Assurance2017-09-22
- NAIDrug Quality Assurance2014-07-16
- VAIVaccines and Allergenic Products2014-01-14
- VAIDrug Quality Assurance2011-07-25
- NAIDrug Quality Assurance2009-07-02
Drugs this plant is listed as making
3 distinct drugs across 5 products name this site in their FDA label.
- Apadamtase AlfaTakeda Pharmaceuticals America, Inc.
- cemiplimab-rwlcRegeneron Pharmaceuticals, Inc.
- TocilizumabBiogen MA Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.